Preeti Dhaka
New York University, Indian Institute of Technology Roorkee
Research areas: Medicine · Infectious Diseases · SARS-CoV-2 and COVID-19 Research · Enzyme Structure and Function · Computational Drug Discovery Methods
0000-0003-3825-7656
About
Preeti Dhaka is a Postdoctoral Researcher at New York University whose research focuses on understanding molecular mechanisms that regulate cell-cycle progression, genome stability, cytokinesis, and cellular homeostasis. Her research integrates molecular biology, biochemistry, structural biology, quantitative biophysics, and computational approaches to elucidate protein–protein and protein–RNA interactions and their roles in cellular function and disease. Her methodological expertise includes protein expression and purification, biochemical and biophysical interaction assays, spectroscopy, X-ray crystallography, cryo-electron microscopy, molecular dynamics simulations, and artificial intelligence–based structural analysis. Her research interests include defining conserved molecular mechanisms governing cell division and identifying molecular vulnerabilities that can be exploited for the development of targeted cancer therapeutics.
Employment
-
New York University Postdoctoral Researcher2026 - Present
-
Indian Institute of Technology Roorkee Research Associate2025 - 2026
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (18)
- Structural Insights and Inhibitor Discovery for Kyasanur Forest Disease Virus NS5 Methyltransferase Save
- Structural and mechanistic insights into dioxin dioxygenase (DxnA1A2) from Rhizorhabdus wittichii RW1: A key enzyme for biodegradation of hazardous dioxins and furans Save
- Expression, purification, and functional characterization of West Nile Virus NS1 in E. coli host expression system Save
- Structural insights into a monoalkyl phthalate hydrolase from Rhodococcus sp. EG-5 for phthalate ester degradation Save
- Structural insights into the RNA binding inhibitors of the C-terminal domain of the SARS-CoV-2 nucleocapsid Save
- Structural and Mechanistic Insights into the Main Protease (Mpro) Dimer Interface Destabilization Inhibitor: Unveiling New Therapeutic Avenues against SARS-CoV-2 Save
- A label-free gold nanoparticles functionalized peptide dendrimer biosensor for visual detection of breakthrough infections in COVID-19 vaccinated patients Save
- Chemical Analysis of Native Himalayan Shilajit: An Evaluation of an Ayurvedic Formulation Save
- Disruption of Molecular Interactions between the G3BP1 Stress Granule Host Protein and the Nucleocapsid (NTD-N) Protein Impedes SARS-CoV-2 Virus Replication Save
- Structural and biochemical analyses reveal quinic acid inhibits DAHP synthase a key player in shikimate pathway Save
- Targeting the host protein G3BP1 for the discovery of novel antiviral inhibitors against Chikungunya virus Save
- Bioinformatics Databases and Tools Available for the Development of Antiviral Drugs Save
- Mechanistic and thermodynamic characterization of antiviral inhibitors targeting nucleocapsid N-terminal domain of SARS-CoV-2 Save
- Sulisobenzone is a potent inhibitor of the global transcription factor Cra Save
- IIT Roorkee researchers discover three antiviral molecules to treat COVID-19 or SARS-CoV-2 virus Save
- MD simulation and MM/PBSA identifies phytochemicals as bifunctional inhibitors of SARS-CoV-2 Save
- Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteins Save
- Virus-host protein-protein interactions as molecular drug targets for arboviral infections Save